BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


Catachem, Inc. Announces FDA Approval of the Lactate Dehydrogenase (LD) In-Vitro Diagnostic (IVD) Chemistry Reagent Kit

Bridgeport, Connecticut, USA (February 20, 1986)…. Catachem, Inc. (Catachem, Private) announced today that it has received 510k clearance from the United States Food and Drug Administration (FDA) for the Lactate Dehydrogenase (LD) in vitro diagnostic chemistry reagent kit.

Measurements of Lactate Dehydrogenase (LD) activity are primarily used for diagnosing myocardial infarctions, myocarditis, cardiac failure with hepatic congestion, liver disease, pernicious anemia, megaloblastic anemia and renal disease, as well as for monitoring the causes and treatments. During a heart attack (or myocardial infarction), damaged heart tissue releases specific proteins called cardiac enzymes. One way to diagnose or confirm a recent heart attack is to test a person's blood for increased levels of these enzymes.  The main enzymes that are measured are troponin I, creatine phosphokinase (CPK, CK), and lactate dehydrogenase (lactic acid dehydrogenase, LDH). Low levels of these enzymes are normally found in your bloodstream, but if your heart muscle is injured (as in a heart attack), the enzymes leak out of damaged heart muscle cells and their levels in the blood rise. CPK is found in the heart muscle, liver, skeletal muscles (such as in the arms and legs), and in the brain. LDH is found in many other body tissues, including the liver, kidneys, skeletal muscles, the brain, and lungs. CPK-MB is a subtype of CPK that is found only in heart muscle. LDH-1 is a subtype of LDH that is found mainly in red blood cells and in heart muscle. Some of these enzymes are also found in other parts of the body besides heart muscle, and their levels in the blood may rise when those other tissues are damaged. However, troponin I is released only by heart muscle. Cardiac enzyme studies must always be interpreted in light of your symptoms, your physical exam findings, and electrocardiography (EKG) results.  All of these tests are done on a sample of blood taken from a vein. LD, Lactate dehydrogenase, Total LDH, and LDH isoenzymes, total and isoenzymes and lactate dehydrogenase (EC 1.1.1.27; L-lactate: NAD oxido reductase) is an enzyme which catalyzes the oxidation of L-lactate to pyruvate with the mediation of NAD as a hydrogen acceptor.  The reaction is reversible and strongly favors the conversion of pyruvate to lactate.  The rate of increase in absorbance of the reaction mixture due to the formation of NADH is proportional to the LD concentration present in the serum sample.  LD is a two reagent chemistry available in two sizes.  Reagents are packaged in small glass bottles. Calibrator and controls are available separately. LD R1 C144-01 6x25 ML, LD R2 C144-02 6x50 ML, LD R1 C142-01 4x500 ML, LD R2 C142-02 5x250 ML.

About Catachem, Inc.

Catachem has a rich 20 year history in clinical chemistry as a manufacturer and distributor of in-vitro chemistry products and services for human, veterinary and environmental laboratories. Catachem chemists helped develop many of the automated diagnostic chemistries widely in use today.  Catachem created the DiscretePak™ and VetSpec™ line of reagents for human and veterinary automated analyzers.  Catachem offers FDA approved (510K) chemistries (liquid and dry) including enzymatic chemistries developed in conjunction with IFCC and CDC.  Catachem has more than 500 applications for all types of analyzers including the Roche, Hitachi, Olympus, AU Series, RA Series, Opera, DAX, Bayer, Advia, Synchron, Beckman, Abbott and many other analyzers.  Corporate headquarters, research, custom formulation laboratories, and manufacturing are located in Bridgeport, Connecticut.  Catachem supplies leading laboratories and equipment manufacturers from distributors around the world. 

Forward-looking statements in this release are made pursuant to the ``safe harbor'' provision of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties including, but not limited to, the results of research and development efforts, the effect of regulation by the United States Food and Drug Administration and other agencies, the impact of competitive products, product development commercialization and technological difficulties, and other risks detailed in the Company's periodic reports filed with the Securities and Exchange Commission.

Keywords: Catachem, Chemistry, Reagents, In-Vitro Diagnostics, IVD, Lactate Dehydrogenase (Total LDH, LDH isoenzymes, Total and Isoenzymes, LD, myocardial infarctions, myocarditis, cardiac failure with hepatic congestion, liver disease, pernicious anemia, megaloblastic anemia, renal disease

For more information contact:

Benjamin Twombly

Catachem, Inc.
70 Hawley Avenue
Bridgeport, CT
USA 06606
+1 (203) 335-9277 Office
+1 (203) 335-9977 FAX
bentwombly@aol.com
catachem@aol.com
www.catacheminc.com

Ref: C3025a

Catachem chemistries include: 5'-Nucleotidase (5NT), Adenosine Deaminase (ADA), Alanine Aminotransferase (ALT), Albumin BCG (ALB), a-L-Fucosidase (AFU), Alkaline Phosphatase (ALP), Ammonia (NH), Amylase (AMY), Aspartate Aminotransferase (ALP), β-Hydroxybutyrate (BHBA), Bicarbonate (HC03), Bile Acids (BA), Bilirubin, Direct with Blank (DBILI), Bilirubin, Total with Blank (TBILI), Bilirubin, Total (TBILI), Blood Urea Nitrogen (BUN), Bromide (BR), CO2 [340] (CO2), CO2 [380] (CO2), CO2 [single reagent] (CO2), Ca+++ Arsenazo [650NM] (CA3), Chloride [340 NM] (CL), Cholesterol (CH), Creatine Kinase (CK), Creatinine (CREAT), Fructosamine [millimole method] (FR), Fructosamine, Glycated Serum Protein [enzymatic] (FR), Gamma-Glutamyl Transpeptidase (GGT), Glucose Hexokinase (GLU), Glycated Hemoglobin (HbA1c), High Density Lipoproteins, Dextran Sulfate (HDL), Inorganic Phosphorus (IP), Lactate Dehydrogenase (LD), Lipase (LIP), Lithium [enzymatic] (LI), Magnesium (MG), N-Acetyl-ß-D-glucosaminidase (NAG), Potassium [enzymatic] (K), Plasma Free Hemoglobin (PFH), Pre-albumin (TBPA), Sodium [enzymatic] (NA), Sorbitol Dehydrogenase (SDH), Thiopurine methyltransferase (TPMT), Total Bile Acids (TBA), Total Iron (TI), Total Protein (TP), Triglycerides (TRIG), UIBC and TIBC (UIBC), Uric Acid (UA), Vitamin B6 (V6B), Multipoint Calibrator Catacal, Catatrol Level 1 Catatrol Level 2, Bile Acids Control, Bile Acids Calibrator, BHBA Calibrator, BHBA Control Level 1, BHBA Control Level 2; Bromide Calibrator, BR Control Level 1, BR Control Level 2; Fructosamine Calibrator, FR Control Level 1, FR Control Level 2, SDH Control Level 1, SDH  Control Level 2.  Call +1 (203) 335-9277 or Write Catachem@aol.com.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.